文献速递主动脉疾病

近肾及肾旁腹主动脉瘤腔内修复与开放修复的短期和长期临床结局:倾向性评分匹配结果——近肾及肾旁主动脉瘤欧洲多中心研究(JAMES)

Short Term and Long Term Clinical Outcomes of Endovascular versus Open Repair for Juxtarenal and Pararenal Abdominal Aortic Aneurysms Using Propensity Score Matching: Results from Juxta- and pararenal aortic Aneurysm Multicentre European Study (JAMES).
PubMed 文献 · Eur J Vasc Endovasc Surg · 2023-02-27

这项回顾性多中心队列研究在五个欧洲高容量学术中心纳入834例连续手术并前瞻随访的近肾或肾旁腹主动脉瘤患者,按1:1倾向性评分匹配为EVAR组和OSR组各145例。随访87个月,两组总生存无差异(EVAR 38.6% vs OSR 42.1%,p=.88);EVAR组主动脉相关再干预更多(24.1% vs 6.9%,p<.001),OSR组急性肾损伤更多(40.7% vs 24.8%,p=.006);院内和30天死亡率无差异。

要点

  • 匹配后EVAR组与OSR组远期总生存无差异(38.6% vs 42.1%,p=.88)。
  • EVAR组主动脉相关再干预率高于OSR组(24.1% vs 6.9%,p<.001)。
  • OSR组急性肾损伤发生率高于EVAR组(40.7% vs 24.8%,p=.006),多可恢复。

核心结论

  • 在高等量主动脉中心,开放手术和腔内修复均可实施,短期死亡率和并发症率低,远期结局良好,这些数据有助于患者在两种术式均可行时做出选择。

研究设计与样本

  • 回顾性多中心队列研究,纳入五个欧洲高容量学术中心(每年>50例开放或50例腔内腹主动脉瘤修复)834例连续手术并前瞻随访的患者。
  • 采用倾向性评分匹配,每例OSR患者与一例EVAR患者按1:1匹配,每组145例。
  • 主要终点为远期全因死亡率,次要终点为免于主动脉相关再干预。

主要发现

  • 随访87个月,两组总生存无差异(EVAR 38.6% vs OSR 42.1%,p=.88)。
  • EVAR组主动脉相关再干预更频繁(24.1% vs 6.9%,p<.001)。
  • OSR组急性肾损伤更常见(40.7% vs 24.8%,p=.006),但多数AKI患者恢复且未进展为肾衰竭。
  • 院内死亡率(EVAR 3.4% vs OSR 4.1%,p=1.0)和30天死亡率(EVAR 4.1% vs OSR 5.5%,p=.80)两组无差异。

临床怎么用

  • 作者指出,在高等量主动脉中心,开放和腔内治疗均可实施,短期死亡率和并发症率低,远期结局良好。
  • 作者指出,这些数据为患者在两种术式均可行时选择术式提供了有用信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to compare the short and long term clinical outcomes of endovascular (EVAR) vs. open surgical repair (OSR) of juxtarenal (JAAAs) and pararenal abdominal aortic aneurysms (PAAAs) in five high volume European academic centres. METHODS: This was a retrospective multicentre cohort study of five high volume European academic centres (> 50 open or 50 endovascular abdominal aortic aneurysm repairs annually) including 834 consecutive patients who were operated on and prospectively followed. Using propensity score matching (PSM) each patient who underwent OSR was matched with one patient who underwent EVAR in a 1:1 ratio (145 patients per group). The primary endpoint was long term all cause mortality, while the secondary endpoint was freedom from aortic related re-intervention. RESULTS: After a follow up of 87 months, no difference in overall survival between the two groups was observed (38.6% for EVAR vs. 42.1% for OSR; p = .88). Patients undergoing EVAR underwent aortic related re-interventions more frequently (24.1% vs. 6.9%; p < .001). Acute kidney injury (AKI) occurred more frequently in patients in the OSR group (40.7% vs. 24.8%; p = .006). However, most patients who suffered from AKI recovered without further progression to renal failure. In hospital (3.4% for EVAR vs. 4.1% for OSR; p = 1.0) and 30 day (4.1% for EVAR vs. 5.5% for OSR; p = .80) mortality rates did not differ between groups. CONCLUSION: Both open and endovascular treatment can be performed in high volume aortic centres with low short term mortality and morbidity rates, and good long term outcomes. These data provide useful information to help patients choose between the two procedures when both are feasible.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Zlatanovic P, Mascia D, Ancetti S, et al. Short Term and Long Term Clinical Outcomes of Endovascular versus Open Repair for Juxtarenal and Pararenal Abdominal Aortic Aneurysms Using Propensity Score Matching: Results from Juxta- and pararenal aortic Aneurysm Multicentre European Study (JAMES). Eur J Vasc Endovasc Surg. 2023. PMID: 36858252. doi:10.1016/j.ejvs.2023.02.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。